Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

419
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
419
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

182
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
182
Neural Regulation01:37

Neural Regulation

39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human immunodeficiency virus accelerates brain aging and disrupts the trajectory of glymphatic clearance in aging brain.

Frontiers in psychiatry·2025
Same author

The invisible architects: microbial communities and their transformative role in soil health and global climate changes.

Environmental microbiome·2025
Same author

Modulation and distribution of extracellular free water and tract deficits in rhesus macaques before and after the initiation of emtricitabine + tenofovir disoproxil fumarate + dotutegravir treatment.

Frontiers in immunology·2025
Same author

Allelochemicals degradation and multifarious plant growth promoting potential of two Bacillus spp.: Insights into genomic potential and abiotic stress alleviation.

Chemosphere·2025
Same author

Bufadienolides from Chansu Injection Synergistically Enhances the Antitumor Effect of Erlotinib by Inhibiting the KRAS Pathway in Pancreatic Cancer.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Highly Air-Stable N-Doped Two-Dimensional Violet Phosphorus with Atomically Flat Surfaces.

ACS nano·2024
Same journal

Effect of acupuncture on rehabilitation treatment of children with different degrees of autism spectrum disorder: a randomized controlled trial.

Frontiers in psychiatry·2026
Same journal

Effectiveness of different digital interventions on symptoms for children and adolescents with attention-deficit/hyperactivity disorder: a network meta-analysis.

Frontiers in psychiatry·2026
Same journal

The therapeutic role of self-transcendence in moral injury recovery: <i>theory, mechanisms, and clinical implications</i>.

Frontiers in psychiatry·2026
Same journal

Detection of depression risk among older adults using home-deployed socially assistive robots: a real-world study.

Frontiers in psychiatry·2026
Same journal

Comparative effectiveness of non-pharmacological interventions on depression and anxiety in aging populations: a systematic review and network meta-analysis of randomized controlled trials.

Frontiers in psychiatry·2026
Same journal

Occupational and psychosocial correlates of sleep disturbance among Chinese expatriate employees in Iraq's Maysan oilfields: a cross-sectional study using regression and network analysis.

Frontiers in psychiatry·2026
See all related articles
  1. Home
  3. Identifying Network State-based Parkinson's Disease Subtypes Using Clustering And Support Vector Machine Models.
  1. Home
  3. Identifying Network State-based Parkinson's Disease Subtypes Using Clustering And Support Vector Machine Models.

Related Experiment Video

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K

Identifying network state-based Parkinson's disease subtypes using clustering and support vector machine models.

Benedictor Alexander Nguchu1,2, Yifei Han1, Yanming Wang3

  • 1Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou Medical University, Wenzhou, Zhejiang, China.

Frontiers in Psychiatry
|February 28, 2025

View abstract on PubMed

Summary
This summary is machine-generated.

Parkinson's disease (PD) exhibits heterogeneity, with subtypes identified through brain imaging and network patterns. Genetic factors like APOE influence these subtypes, paving the way for personalized treatments.

Keywords:
APOE genotypePD heterogeneityPD subtypesParkinson’s diseaseclustering algorithmmachine learning models

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.0K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.7K

Related Experiment Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.0K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.7K

Area of Science:

  • Neuroscience
  • Genetics
  • Machine Learning

Background:

  • Parkinson's disease (PD) heterogeneity complicates the development of effective therapeutic targets.
  • Identifying distinct PD subtypes is crucial for advancing personalized medicine.

Purpose of the Study:

  • To identify network-specific patterns characterizing PD subtypes using clustering algorithms.
  • To evaluate the diagnostic power of brain features and network patterns in differentiating PD subtypes.
  • To investigate the association between PD subtypes and APOE genotype.

Main Methods:

  • Applied K-means and hierarchical clustering to Parkinson's Progression Markers Initiative (PPMI) data.
  • Utilized gray matter volume and dopaminergic features of the neostriatum (caudate, putamen, anterior putamen).
  • Employed machine learning (ML) algorithms (Random Forest, Logistic Regression, SVM) for classification and biomarker evaluation.

    • Main Results:

    • Identified three network states: one for healthy controls (HC) and two distinct PD subtypes.
    • Found significant dopaminergic deficit (DAT) in PD patients, accelerated by APOE ε2/ε4.
    • ML models, particularly SVM, achieved high accuracy (99.3%) in classifying PD subtypes using brain features and network patterns.

    Conclusions:

    • PD exhibits intrinsic heterogeneity influenced by genetic factors, particularly APOE genotype.
    • Network states and ML models can characterize PD subtypes, offering insights for personalized drug development.
    • Distinct PD subtypes show varying levels of gray matter volume and DAT deficits.